---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-037412"
form_type: "8-K"
ticker: "CC"
cik: "0001627223"
company_name: "Chemours Co"
filed_at: "2024-03-28T23:59:59+00:00"
generated_at: "2026-06-04T06:13:13.226863+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Chemours Q4 adjusted EPS $0.31 vs $0.00 YoY; full year net loss $238M on $764M litigation charges

## Summary
- Q4 2023 net sales $1.4B (+2% YoY); full year net sales $6.0B (-11% YoY).
- Q4 net loss $18M ($0.12 loss/diluted); adjusted net income $46M ($0.31 diluted EPS).
- Full year net loss $238M ($1.60 loss/share); adjusted net income $425M ($2.82 EPS) vs $738M prior.
- Adjusted EBITDA Q4 $176M vs $120M prior; full year $1.0B vs $1.4B, impacted by $89M/$764M litigation charges.
- Segment: TT +7%, TSS +17%, APM -15%; CEO cites destocking and progress on legacy environmental matters.

## SEC filing metadata
- accession: 0000950170-24-037412
- form_type: 8-K
- ticker: CC
- cik: 0001627223
- company_name: Chemours Co
- filed_at: 2024-03-28T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1627223/000095017024037412/0000950170-24-037412-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1627223/000095017024037412/cc-20240327.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-037412
- JSON: https://secwatch.observer/filing/0000950170-24-037412.json
- Plain text: https://secwatch.observer/filing/0000950170-24-037412.txt

## Key facts
- Earnings Releases
  Chemours Co reported fourth quarter and full year 2023 results: revenue Net Sales of $1.4 billion, net income Net Loss attributable to Chemours of $18 million, or a loss of $0.12 per diluted share, EPS Net Loss attributable to Chemours of $18 million, or a loss of $0.12 per diluted share.
  - Period: fourth quarter and full year 2023
  - Revenue: Net Sales of $1.4 billion
  - Net income: Net Loss attributable to Chemours of $18 million, or a loss of $0.12 per diluted share
  - EPS: Net Loss attributable to Chemours of $18 million, or a loss of $0.12 per diluted share
  - Result: reported results
  source text: The Chemours Company Reports Fourth Quarter and Full Year 2023 Results Wilmington, Del., March 27, 2024 – The Chemours Company (“Chemours” or “the Company”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies (“TT”), Thermal & Specialized Solutions (“TSS”), and Advanced Performance Materials (“APM”), today announced its financial results for the fourth quarter and full year 2023. Key Fourth Quarter 2023 Results • Net Sales of $1.4 billion, up 2% year-over-year • Net Loss attributable to Chemours of $18 million, or a loss of $0.12 per diluted share
  evidence_url: https://www.sec.gov/Archives/edgar/data/1627223/000095017024037412/0000950170-24-037412-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.